Anzeige
Mehr »
Login
Donnerstag, 18.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Kurze Gold-Preis-Konsolidierung zum Einstieg in diese Aktie nutzen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 20.12.2014

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
20.12.14Chen Long Charges to BWF Destination Dubai World Superseries Men's Singles Final46DUBAI, UAE, December 20, 2014 /PRNewswire/ -- China's World champion and tournament top seed Chen Long survived a scare against India's Kidambi Srikanth tonight on his way to the Men's Finals of...
► Artikel lesen
20.12.14England's Adcocks Felled By Illness In Semis Of BWF Destination Dubai World Superseries Finals97DUBAI, UAE, December 20, 2014 /PRNewswire/ -- After forcing their way into the Mixed Doubles semi-finals of the BWF Destination Dubai World Superseries Finals with a hard fought win over Germany's...
► Artikel lesen
20.12.14IZON And Stream TV Team Up For Glasses-Free 3D Product Launch29PHILADELPHIA, Dec. 20, 2014 /PRNewswire/ -- Stream TV Networks, Inc.' is pleased to announce that U.S. television maker IZON, LLC has committed to a 2015 release of Ultra-D enabled products in collaboration...
► Artikel lesen
20.12.14Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze (asparaginase Erwinia chrysanthemi)76-- Expanded U.S. Labeling Offers an Alternative Method to Administer Erwinaze to Patients with ALL DUBLIN, Dec. 20, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced...
► Artikel lesen
20.12.14AIMCo Announces Designation of Mac Van Wielingen as Chair of the Board of Directors27EDMONTON, Alberta, December 19, 2014 /PRNewswire/ -- Alberta Investment Management Corporation (AIMCo) is pleased to announce the designation of Mac Van Wielingen as Chair of the Board of Directors....
► Artikel lesen
20.12.14AbbVie Receives U.S. FDA Approval of VIEKIRA PAK' (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C90- In Phase 3 clinical trials, VIEKIRA PAK cured 95-100 percent of hepatitis C patients, with less than 2 percent of patients experiencing virological failure - Tolerability profile shows...
► Artikel lesen